AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company and ...

"CGIE (TM) is being built as future-facing infrastructure rather than a point solution," said Yusuf Henriques, Founder and CEO of IndyGeneUS Bio. "Our objective is to establish the AI×Bio Factory--the ...

This expansion is in addition to the previously announced Microsoft (MSFT) for Startups program. PredicTcell, Tevogen Bio’s proprietary technology, is designed for predictive, precision T cell target ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. There’s more to life than protein folding. You’d be forgiven for believing ...

Xellar Biosystems ("Xellar"), a globally leading innovator in next-generation artificial intelligence- and computer vision–assisted, organ-on-a-chip–based drug discovery and development platforms, ...

The Bio-Intelligence Initiative investigates how coherent and low-noise neural states observed in the human brain can serve ...

Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I analyze the recently announced ...